Actively Recruiting
New Diagnostic Methods and Treatments for Endometriosis Focusing on Prognosis and Prevention of Complications
Led by Turku University Hospital · Updated on 2021-08-16
230
Participants Needed
4
Research Sites
156 weeks
Total Duration
AI-Summary
What this Trial Is About
Endometriosis is a long-lasting condition where tissue similar to the lining inside the uterus grows outside it, causing pain and fertility problems for many women of reproductive age. This research aims to find specific RNA and protein markers in endometriosis tissue and normal uterine lining to help develop new treatments and diagnostic tools. The study also seeks to identify markers that predict disease progression and infertility through a detailed 10-year follow-up. Participants include women aged 19 to 48 years either with surgically confirmed endometriosis or healthy women without endometriosis confirmed by laparoscopy during sterilization. The study involves collecting tissue samples during surgery by laparoscopy or laparotomy for analysis of hormone metabolism and gene expression. Healthy volunteers are also included to provide comparison samples. During the study, researchers will collect samples during surgery and follow participants annually for up to 10 years using questionnaires about pain symptoms, fertility, and treatments. The study measures hormone levels and gene expression in tissues and blood, and tracks pain recurrence after surgery. This long-term follow-up aims to better understand disease behavior and support development of personalized treatment options.
CONDITIONS
Brief Title
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
Research Team
A
Antti H Perheentupa, MD PhD
K
Kaisa Huhtinen, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here